Download PDF
Int J Sports Med 2007; 28(9): 722-726
DOI: 10.1055/s-2007-964891
Physiology & Biochemistry

© Georg Thieme Verlag KG Stuttgart · New York

Effect of Aspirin and Ibuprofen on GI Permeability during Exercise

G. P. Lambert1 , M. Boylan2 , J.-P. Laventure1 , A. Bull1 , S. Lanspa3
  • 1Department of Exercise Science and Athletic Training, Creighton University, Omaha, United States
  • 2Department of Biology, Creighton University, Omaha, United States
  • 3Department of Medicine, Creighton University, Omaha, United States
Further Information

Publication History

accepted after revision September 21, 2006

Publication Date:
13 April 2007 (online)

Also available at
    Permissions and Reprints

Abstract

This study was conducted to determine the effects of aspirin or ibuprofen on gastrointestinal permeability when combined with exercise. Eight runners completed three 60 min treadmill runs at 70 % V·O2max. For 24 hours prior to each run, subjects ingested aspirin (2 × 325 mg), ibuprofen (2 × 200 mg), or placebo capsules every 6 hours. Immediately before each run, a solution containing 5 g sucrose, 5 g lactulose, and 2 g rhamnose was ingested. Urine produced during each run, and for 4 h afterwards was collected. Urinary excretion of sucrose is an indicator of gastroduodenal permeability. The excretion ratio of lactulose-to-rhamnose assesses small intestinal permeability. Sucrose excretion (%) was greater (p < 0.017) for aspirin (0.37 [0.2 - 0.97]) compared to placebo (0.09 [0.05 - 0.30]) or ibuprofen (0.22 [0.1 - 0.39]) and sucrose excretion for ibuprofen was greater than placebo. The lactulose-to-rhamnose ratio was greater for aspirin (0.09 [0.08 - 0.30]) than placebo (0.065 [0.04 - 0.08]) however ibuprofen (0.08 [0.06 - 0.19]) was not different from aspirin or placebo. These results indicate that with prolonged running, gastroduodenal permeability is increased if aspirin or ibuprofen is used prior to such exercise. Furthermore, aspirin promotes greater gastroduodenal permeability and also increases small intestinal permeability.

Key words

running - stomach - intestine

References

  • 1 Ashton T, Young I S, Davison G W, Rowlands C C, McEneny J, Blerk C V, Jones E, Peters J R, Jackson S K. Exercise-induced endotoxemia: The effect of ascorbic acid supplementation.  Free Rad Biol Med. 2003;  35 284-291
    CrossrefPubMedGoogle Scholar
  • 2 Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview.  Gastroenterology. 1995;  108 1566-1581
    CrossrefPubMedGoogle Scholar
  • 3 Bjarnason I, Williams P, Smethurst P, Peters T J, Levi A J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.  Gut. 1986;  27 1292-1297
    CrossrefPubMedGoogle Scholar
  • 4 Bjarnason I, Zanelli G, Prouse P, Williams P, Gumpel M J, Levi A J. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.  Drugs. 1986;  32 (Suppl 1) 35-41
    CrossrefPubMedGoogle Scholar
  • 5 Bouchama A, Parhar R S, El-Yazigi A, Sheth K, Al-Sedairy S. Endotoxemia and release of tumor necrosis factor and interleukin 1-alpha in acute heatstroke.  J Appl Physiol. 1991;  70 2640-2644
    PubMedGoogle Scholar
  • 6 Brock-Utne J G, Gaffin S L, Wells M T, Gathiram P, Sohar E, James M F, Morrell D F, Norman R J. Endotoxemia in exhausted runners after a long-distance race.  S African Med J. 1988;  73 533-536
    PubMedGoogle Scholar
  • 7 Garnett W R. GI effects of OTC analgesics: implications for product selection.  J Am Pharm Assoc. 1996;  NS36 565-572
    PubMedGoogle Scholar
  • 8 Gisolfi C V. Is the GI system built for exercise?.  NIPS. 2000;  15 114-119
    PubMedGoogle Scholar
  • 9 Jackson L M, Hawkey C J. NSAIDs and the GI tract-potential hazards and benefits.  Apoptosis. 1999;  4 397-402
    CrossrefPubMedGoogle Scholar
  • 10 Jeukendrup A E, Vet-Joop K, Sturk A, Stegen J H, Senden J, Saris W H, Wagenmakers A J. Relationship between gastro-intestinal complaints and endotoxemia, cytokine release and the acute-phase reaction duirng and after a long-distance triathlon in highly trained men.  Clin Sci (Lond). 2000;  98 47-55
    CrossrefPubMedGoogle Scholar
  • 11 Lambert G P. Role of gastrointestinal permeability in exertional heatstroke.  Exer Sport Sci Rev. 2004;  32 185-190
    PubMedGoogle Scholar
  • 12 Lambert G P, Broussard L J, Mason B L, Mauermann W J, Gisolfi C V. Gastrointestinal permeability during exercise: effects of aspirin and energy-containing beverages.  J Appl Physiol. 2001;  90 2075-2080
    PubMedGoogle Scholar
  • 13 Meddings J B, Sutherland L R, Byles N I, Wallace J L. Sucrose: a novel permeability marker for gastroduodenal disease.  Gastroenterology. 1993;  104 1619-1626
    PubMedGoogle Scholar
  • 14 Otte J A, Oosteveen E, Geelkerken R H, Groeneveld A BJ, Kolkman J J. Exercise induces gastric ischemia in healthy volunteers: a tonometry study.  J Appl Physiol. 2001;  91 866-871
    PubMedGoogle Scholar
  • 15 Pals K L, Chang R T, Ryan A J, Gisolfi C V. Effect of running intensity on intestinal permeability.  J Appl Physiol. 1997;  82 571-576
    PubMedGoogle Scholar
  • 16 Payan D G, Shearn M A. Nonsteroidal anti-inflammatory drugs; nonopioid analgesics; drugs used in gout. Katzung BG Basic and Clinical Pharmacology. 4th ed. Norwalk; Appleton & Lang 1989: 431-450
    Google Scholar
  • 17 Perko M J, Nielsen H B, Skak C, Clemmesen J O, Schroeder T V, Secher N H. Mesenteric, coeliac, splanchnic blood flow in humans during exercise.  J Physiol. 1998;  513.3 907-913
    PubMedGoogle Scholar
  • 18 Qamar M I, Read A E. Effects of exercise on mesenteric blood flow in man.  Gut. 1987;  28 583-587
    CrossrefPubMedGoogle Scholar
  • 19 Rowell L B. Human cardiovascular adjustments to exercise and thermal stress.  Physiol Rev. 1974;  54 75-159
    PubMedGoogle Scholar
  • 20 Ryan A J, Chang R-T, Gisolfi C V. Gastrointestinal permeability following aspirin intake and prolonged running.  Med Sci Sports Exerc. 1996;  28 698-705
    PubMedGoogle Scholar
  • 21 Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, Scott D, Gumpel M J, Bjarnason I. Intestinal permeability and inflammation in patients on NSAIDS.  Gut. 1998;  43 506-511
    CrossrefPubMedGoogle Scholar
  • 22 Somasundaram S, Hayllar H, Rafi S, Wrigglesworth J M, Macpherson A JS, Bjarnson I. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis.  Scand J Gastroent. 1995;  30 289-299
    CrossrefPubMedGoogle Scholar
  • 23 Somasundaram S, Sigthorsson G, Simpson R J, Watts J, Jacob M, Tavares I A, Rafi S, Roseth A, Foster R, Price A B, Wrigglesworth J M, Bjarnason I. Uncoupling of intestinal mitochondiral oxidative phosphorylation and inhibition of cyclooxygenase are requried for the development of NSAID-enteropathy in the rat.  Aliment Pharmacol Ther. 2000;  15 639-650
    PubMedGoogle Scholar
  • 24 Sutherland L R, Verhoef M, Wallace J L, Rosendaal Gv, Crutche R, Meddings J B. A simple, non-invasive marker of gastric damage: sucrose permeability.  Lancet. 1994;  343 998-1000
    CrossrefPubMedGoogle Scholar
  • 25 Tomlinson J, Blikslager A. Role of nonsteroidal anti-inflammatory drugs in gastrointestinal tract injury and repair.  JAVMA. 2003;  222 946-951
    PubMedGoogle Scholar
  • 26 Travis S, Menzies I. Intestinal permeability: functional assessment and significance.  Clin Sci. 1992;  82 471-488
    PubMedGoogle Scholar
  • 27 van Niewenhoven M A, Brouns F, Brummer R-J M. Gastrointestinal profile of symptomatic athletes at rest and during physical exercise.  Eur J Appl Physiol. 2004;  91 429-434
    PubMedGoogle Scholar
  • 28 van Niewenhoven M A, Vriens B EPJ, Brummer R-J M, Brouns F. Effect of dehydration on gastrointestinal function at rest and during exercise in humans.  Eur J Appl Physiol. 2000;  83 578-584
    CrossrefPubMedGoogle Scholar

PhD G. Patrick Lambert

Department of Exercise Science and Athletic Training
Creighton University

2500 California Plaza

Room 225 KFC

68178 Omaha

United States

Phone: + 40 22 80 24 20

Fax: + 40 22 80 47 32

Email: plambert@creighton.edu

      >